P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells
- PMID: 15962371
- PMCID: PMC4315957
- DOI: 10.3748/wjg.v11.i23.3544
P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells
Abstract
Aim: To verify whether P-glycoprotein (P-gp) could induce cell resistance to apoptosis by inhibiting caspase-8 and caspase-3.
Methods: Human KB cells, either drug-sensitive or with multidrug resistance (MDR) phenotype caused by overexpression of P-gp (KBv200 cells), were treated with anti-Fas (CH-11 monoclonal antibody) to induce apoptosis. Cytotoxicity was detected by MTT assay. Symptoms of cell death were assessed by morphological observation after Hoechst33258 staining, activation of caspase-8 and caspase-3 was measured by Western blotting.
Results: Compared with KB cells, the resistance of KBv200 cells to VCR (vincristine) was about 51-fold higher. Anti-Fas (CH-11) induced cytotoxicity and apoptosis in both sensitive KB cells and MDR phenotype KBv200 cells. The IC50 of CH-11 in KB cells was similar to that in KBv200 cells. CH-11 induced similar apoptotic rates in both KB cells and KBv200 cells, which could be classified as caspase-dependent apoptotic pathway. Verapamil (VRP) did not affect CH-11-mediated apoptosis in KBv200 cells.
Conclusion: Expression of P-glycoprotein does not induce resistance to caspase-8 and -3 activation or anti-Fas-induced cell apoptosis.
Figures





Similar articles
-
The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.Cytometry. 2001 Mar 1;43(3):189-94. doi: 10.1002/1097-0320(20010301)43:3<189::aid-cyto1048>3.0.co;2-w. Cytometry. 2001. PMID: 11170105
-
[Study on apoptosis of oral squamous carcinoma cell line KB and KBv200 induced by survivin RNAi].Ai Zheng. 2006 Aug;25(8):933-40. Ai Zheng. 2006. PMID: 16965671 Chinese.
-
P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.Blood. 1999 Feb 1;93(3):1075-85. Blood. 1999. PMID: 9920858
-
Drug resistance does not correlate with resistance to Fas-mediated apoptosis.Leuk Res. 2001 Jan;25(1):69-75. doi: 10.1016/s0145-2126(00)00085-0. Leuk Res. 2001. PMID: 11137563
-
Death receptors, intimal disease, and gene therapy: are therapies that modify cell fate moving too Fas?Circ Res. 2000 May 26;86(10):1009-12. doi: 10.1161/01.res.86.10.1009. Circ Res. 2000. PMID: 10827127 Review. No abstract available.
Cited by
-
Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells.Molecules. 2014 Aug 25;19(9):13061-75. doi: 10.3390/molecules190913061. Molecules. 2014. PMID: 25157469 Free PMC article.
-
Evaluation of Apoptosis in Multipotent Hematopoietic Cells of Bone Marrow by Anthracycline Antibiotics.Iran J Pharm Res. 2017 Summer;16(3):1204-1213. Iran J Pharm Res. 2017. PMID: 29201109 Free PMC article.
-
Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro.Oncol Rep. 2017 Jan;37(1):31-40. doi: 10.3892/or.2016.5230. Epub 2016 Nov 8. Oncol Rep. 2017. PMID: 27840996 Free PMC article.
References
-
- Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989;58:137–171. - PubMed
-
- Inoue S, Salah-Eldin AE, Omoteyama K. Apoptosis and anticancer drug resistance. Hum Cell. 2001;14:211–221. - PubMed
-
- Tolomeo M, Simoni D. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies. Curr Med Chem Anticancer Agents. 2002;2:387–401. - PubMed
-
- Adams J. The proteasome: structure, function, and role in the cell. Cancer Treat Rev. 2003;29 Suppl 1:3–9. - PubMed
-
- Brown JM, Wilson G. Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? Cancer Biol Ther. 2003;2:477–490. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous